Akoya Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year 2022
For the fiscal year of 2022, revenue is expected to be between $74.3 million and $74.8 million, as compared to $54.9 million for fiscal year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | -4.10% | -0.85% | -52.05% |
1st Jan change | Capi. | |
---|---|---|
-52.05% | 116M | |
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |